![Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822002161-fx1.jpg)
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect
![An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6605283/MediaObjects/41416_2009_Article_BF6605283_Fig2_HTML.jpg)
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016 Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016](https://journals.sagepub.com/cms/10.2217/whe.15.92/asset/images/large/10.2217_whe.15.92-fig2.jpeg)
Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016
![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
![Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy](https://pub.mdpi-res.com/cancers/cancers-14-03848/article_deploy/html/images/cancers-14-03848-g001.png?1660053841)
Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
![Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-021-06113-x/MediaObjects/10549_2021_6113_Fig5_HTML.png)
Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator | SpringerLink
![PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation](https://i1.rgstatic.net/publication/317157626_An_updated_PREDICT_breast_cancer_prognostication_and_treatment_benefit_prediction_model_with_independent_validation/links/59728b0b0f7e9b401694486e/largepreview.png)
PDF) An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
![Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda](https://integrativeoncology-essentials.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-28-at-11.39.28-AM-519x1024.png)
Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr2.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/57900c48-ea3e-4a94-83a6-3ca44db35abd/mfig005.jpg)
Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![CBCRisk model to determine the risk of contralateral breast cancer in sporadic breast cancer | Cirugía Española (English Edition) CBCRisk model to determine the risk of contralateral breast cancer in sporadic breast cancer | Cirugía Española (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//21735077/0000009900000010/v1_202112030810/S2173507721002593/v1_202112030810/en/main.assets/fx1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNevDmstseIgSbQDOqjN6Vz81LvVlEPLU6IFCmpBS6ZXrqbXpbOGNSgzqfMrDozVhYk20NmTEb/ZHBNXIzEaWR7qXmxWZU/bZ5fXVIYKXFnGrnZPsoZLAVpCOoZOQKKr1jdvbSxI0QFMVvz3X/E8NOA3St23867oS90yCnrzSVDWhU4Iax7FO4oV+T5m/pBRUSGLtwn89rymFsgu/HrgulKLuZ8zVgg/L0wHJ4VD1sDsTqYIYnnT0c6F8bkHQvPk4Go=)